We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global PEGylated Proteins Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global PEGylated Proteins Market was valued at USD 690.54 million in 2016 and is projected to reach USD 1686.45 million by 2025, growing at a CAGR of 10.43% from 2017 to 2025.
PEGylation (often styled pegylation) is the process of both covalent and non-covalent attachment or amalgamation of polyethylene glycol polymer chains to molecules and macrostructures, such as a drug, therapeutic protein or vesicle, which is then described as PEGylated (pegylated).

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Growing R&D Spending
1.2 Rising Biologics Sector
1.3 Technological developments in Protein Based Drugs and Non Protein Based drugs
1.4 Growing Protein's Stability
1.5 Major Lifestyle changes and associated diseases

2. Market Restraints
2.1 Drug Failure and Recalls Hinders Market Growth

Market Segmentation:
1. Global PEGylated Proteins Market, by End User:
1.1 Pharmaceutical & Biotechnology Companies
1.2 Contract Research Organization
1.3 Academic Research Institutes

2. Global PEGylated Proteins Market, by Application:
2.1 Cancer Treatment
2.2 HEPAtitis
2.3 Chronic Kidney Disease
2.4 Hemophilia
2.5 Multiple Sclerosis
2.6 Gastrointestinal Disorder
2.7 Other Application

3. Global PEGylated Proteins Market, by Protein Type:
3.1 Colongy Stimulating Factors
3.2 Interferons
3.3 Erythropoietin (EPO)
3.4 Recombinant Factor Viii
3.5 Monoclonal Antibodies
3.6 Other Protein Type

4. Global PEGylated Proteins Market, by Product:
4.1 Consumables
4.1.1 Pegylation Kits
4.1.2 Pegylation Reagents
4.1.2.1 Monofunctional Linear Pegs
4.1.2.2 Bifunctional Pegs
4.1.2.3 Multi-Arm Pegs
4.1.2.4 Branched Pegs
4.1.2.5 Other Pegylation Reagents
4.2 Services
4.2.1 Development of PEGylated Biosimilars
4.2.2 Process Development of Peg-Drug Conjugate Manufacturing
4.2.3 Pilot Production of Peg Drug Conjugate
4.2.4 Development of Analytical Methods
4.2.5 Pegylation Feasibility Studies

5. Global PEGylated Proteins Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Merck Millipore
2. Thermo Fisher Scientific Inc.
3. NOF American Corporation (A Subsidiary of NOF Corporation)
4. Jenkem Technology
5. Creative Pegworks
6. Celares GmbH
7. Quanta Biodesign, Ltd
8. Biomatrik, Inc.
9. Iris Biotech GmbH
10. Laysan Bio, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the PEGylated ProteinsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL PEGYLATED PROTEINSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PEGYLATED PROTEINSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PEGYLATED PROTEINS MARKET, BY END USER
5.1 Pharmaceutical & Biotechnology Companies
5.2 Contract Research Organization
5.3 Academic Research Institutes

6 GLOBAL PEGYLATED PROTEINS MARKET, BY APPLICATION
6.1 Cancer Treatment
6.2 HEPAtitis
6.3 Chronic Kidney Disease
6.4 Hemophilia
6.5 Multiple Sclerosis
6.6 Gastrointestinal Disorder
6.7 Other Application

7 GLOBAL PEGYLATED PROTEINS MARKET, BY PROTEIN TYPE
7.1 Colongy Stimulating Factors
7.2 Interferons
7.3 Erythropoietin (EPO)
7.4 Recombinant Factor Viii
7.5 Monoclonal Antibodies
7.6 Other Protein Type

8 GLOBAL PEGYLATED PROTEINS MARKET, BY PRODUCT
8.1 Consumables
8.1.1 Pegylation Kits
8.1.2 Pegylation Reagents
8.1.2.1 Monofunctional Linear Pegs
8.1.2.2 Bifunctional Pegs
8.1.2.3 Multi-Arm Pegs
8.1.2.4 Branched Pegs
8.1.2.5 Other Pegylation Reagents
8.2 Services
8.2.1 Development of PEGylated Biosimilars
8.2.2 Process Development of Peg-Drug Conjugate Manufacturing
8.2.3 Pilot Production of Peg Drug Conjugate
8.2.4 Development of Analytical Methods
8.2.5 Pegylation Feasibility Studies

9 GLOBAL PEGYLATED PROTEINSMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL PEGYLATED PROTEINSMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Merck Millipore
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Thermo Fisher Scientific Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 NOF American Corporation (A Subsidiary of NOF Corporation)
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Jenkem Technology
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Creative Pegworks
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Celares GmbH
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Quanta Biodesign, Ltd
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Biomatrik, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Iris Biotech GmbH
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Laysan Bio, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

12 Appendix
12.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved